Skip to main content

Table 2 Prevalence of carriage of macrolide resistance bacteria

From: Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial

Time of sampling

Placebo (n = 91)

Azithromycin (n = 91)

Baseline

29/30 (96.7%)

29/30 (96.7%)

24-month follow-up

61/61 (100.0%)

60/61 (98.4%)

  1. Carriage of macrolide resistance was defined as the presence of any bacterium carrying any macrolide resistance allele